Publication | Closed Access

Flecainide therapy suppresses exercise-induced ventricular arrhythmias in patients with CASQ2-associated catecholaminergic polymorphic ventricular tachycardia

Cardiac MuscleCardiomyopathyExercise-induced Ventricular ArrhythmiasCardiogenic ShockCardiovascular DiseaseMedicinePhysiologyPharmacotherapyElectrophysiologyFlecainide TherapyPublic HealthPharmacologyCardiologyArrhythmia